Thymosin beta-4 protected corneal stromal cells from ethanol-induced oxidative stress and apoptosis while promoting cell proliferation and wound healing in both cell and mouse models.
Both in vitro and in vivo protectionTβ4 showed consistent protective effects in human corneal cells and mouse corneas, strengthening the case for clinical translation
What the researchers found
Thymosin beta-4 alleviated ethanol-induced oxidative stress and apoptosis in human corneal keratocytes by upregulating protective factors (Bcl-2, catalase, CuZnSOD) and inhibiting the cell death marker Caspase-3. Tβ4 also promoted cell proliferation through upregulated Ki67 expression and accelerated corneal wound healing in both in vitro and in vivo models. In mouse corneas treated with ethanol, Tβ4 promoted reconstruction of the damaged corneal stroma, confirmed by fluorescein sodium staining and histological examination.
Why it matters
Corneal damage from ethanol exposure during eye surgery is a real clinical problem. This research suggests thymosin beta-4 could be developed as a protective eye drop or treatment to reduce corneal damage and speed recovery after procedures that involve alcohol contact with the cornea.
How the study worked
Researchers used human corneal keratocytes (HCKs) and BALB/c mice to create ethanol injury models both in vitro and in vivo. Cell metabolic activity was measured with CCK-8 assay. Reactive oxygen species were detected using DCFH-DA. Apoptosis was assessed by TUNEL staining. Cell proliferation and migration were measured with wound healing insert assays. In mice, corneal healing was tracked with fluorescein staining and H&E histology. Gene and protein expression were analyzed by RT-qPCR, ELISA, and immunostaining.
What this study cannot tell us
The study used cell culture and mouse models, which may not fully replicate human corneal healing. Specific dosing, treatment timing, and concentration-response relationships were not detailed in the abstract. Long-term safety and efficacy of Tβ4 for corneal applications were not assessed. The mouse cornea differs from the human cornea in size and structure.
How to read the evidence
This is a preclinical study using both cell culture and animal models with multiple validated assays. The dual-model approach strengthens confidence, but human clinical data is still needed.
When this study was published
Published in 2022, this study builds on established thymosin beta-4 wound healing research and is relevant to ongoing clinical development of Tβ4 eye drops.
The bigger picture
Thymosin beta-4 is already known for promoting wound healing in various tissues. This study extends its therapeutic potential to ophthalmology, specifically corneal surgery recovery. With Tβ4 eye drops (RegeneRx's RGN-259) already in clinical trials for dry eye disease, demonstrating protective effects against surgical corneal injury could broaden its clinical applications.
Questions still open
- Could Tβ4 eye drops be used prophylactically before LASIK or other corneal procedures to prevent ethanol damage?
- What is the optimal concentration and timing of Tβ4 application for maximum corneal protection?
- Does Tβ4's corneal protection extend to other types of surgical or chemical injury beyond ethanol?
Common questions
How does thymosin beta-4 protect corneal cells?
Could this lead to better recovery after eye surgery?
Read the original research
Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte.
BMC ophthalmology, 22(1), 33
Citation
Liu, Jinghua; Guo, Chen; Hao, Peng; Wang, Peihong; Li, Linghan; Wang, Yuchuan; Li, Xuan. (2022). Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte.. BMC ophthalmology, 22(1), 33. https://doi.org/10.1186/s12886-022-02255-8